Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,902 | -19,128 | -29,499 | -25,451 | -23,553 |
| Depreciation Amortization | 1,504 | 1,940 | 1,967 | 2,138 | 1,459 |
| Accounts receivable | 209 | -3,999 | -3,278 | -135 | -400 |
| Accounts payable and accrued liabilities | 932 | -637 | 135 | 1,537 | -575 |
| Other Working Capital | 1,869 | -2,667 | -2,455 | 436 | -1,203 |
| Other Operating Activity | 880 | 4,978 | 4,410 | -284 | 1,966 |
| Operating Cash Flow | $-11,508 | $-19,513 | $-28,720 | $-21,759 | $-22,306 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,529 | -688 | -910 | -973 | -2,932 |
| Purchase Of Investment | 0 | 0 | -4,511 | -6,286 | -1,990 |
| Sale Of Investment | 0 | 0 | 10,797 | 500 | 1,987 |
| Other Investing Activity | 196 | 0 | 625 | 19 | -8 |
| Investing Cash Flow | $-1,333 | $-688 | $6,001 | $-6,740 | $-2,943 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,125 | 10,510 | 10,000 | 5,000 | 13,000 |
| Debt Repayment | 0 | -1,034 | -3,855 | -3,503 | -4,000 |
| Common Stock Issued | 39 | 53 | 180 | 147 | 190 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -69 |
| Other Financing Activity | 633 | 7,410 | 0 | 35,911 | 22,003 |
| Financing Cash Flow | $3,797 | $16,939 | $6,325 | $37,555 | $31,124 |
| Exchange Rate Effect | 165 | 68 | 113 | 3 | -19 |
| Beginning Cash Position | 14,602 | 17,796 | 34,077 | 25,018 | 19,162 |
| End Cash Position | 5,723 | 14,602 | 17,796 | 34,077 | 25,018 |
| Net Cash Flow | $-8,879 | $-3,194 | $-16,281 | $9,059 | $5,856 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,508 | -19,513 | -28,720 | -21,759 | -22,306 |
| Capital Expenditure | -1,539 | -799 | -910 | -973 | -2,932 |
| Free Cash Flow | -13,047 | -20,312 | -29,630 | -22,732 | -25,238 |